Effects of protiens on GH secretory patterns in obese and non-obese elderly

Completed

• Conditions: sarcopenie en obesitas; loss of muscle mass due to elderly; musclemassloss

• Registration Number: NL-OMON32139
• Lead Sponsor: niversiteit Maastricht, Human Biology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 13 May 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 16

Inclusion Criteria

women, post-menopausal, age between 55-65, 8 visceral obese (BMI 27-33 and Waist/hip-ratio>0.85), 8 normal weight (BMI20-25, wasit/hip<0.85)

Exclusion Criteria

Use of medication, instabel weight, disorders as cardiovascular diseases, diabetics, cancer, gelatin-allergic

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The main endpoint of the study is the GH-concentration after ingestion of<br /><br>placebo and protein. This is determined by blood-sampling. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The second study endpoint is the insulin-concentration after ingestion of<br /><br>placebo and protein. This is determined by blood-sampling.<br /><br>Another endpoint is the correlation between the effect of standard clinical<br /><br>GHST and the protein-drink on GH-secretion.<br /><br>Correlation between the amount of visceral fat mass (estimated with DXA) and<br /><br>the GH concentrations after standard clinical GHST and protein-drink. </p><br>